Effects of Isolated Systolic Hypertension
Links shared publicly online about this topic
Isolated systolic hypertension: A health concern? - MayoClinic.com
mayoclinic.com — “High systolic blood pressure (isolated systolic hypertension) is as important as high diastolic blood pressure.” View full resource at mayoclinic.com
Most Recently Shared on July 9, 2011 at 2:25 am By:
Isolated systolic hypertension: A health concern?: High systolic blood pressure (isolated systolic hypertension)... http://bit.ly/qrrkJl
OhioHealth - Isolated systolic hypertension: A health concern?
ohiohealth.com — “High systolic pressure (isolated systolic hypertension) is as important as high diastolic pressure.” View full resource at ohiohealth.com
Most Recently Shared on March 25, 2009 at 12:23 pm By:
OhioHealthy Tip: Isolated systolic hypertension: A health concern? http://is.gd/oSaF
Aliskiren combination therapy helped improve systolic BP
endocrinetoday.com — “Results from two studies suggested that a combination hypertension therapy aliskiren plus hydrochlorothiazide was more effective t” View full resource at endocrinetoday.com
Most Recently Shared on May 4, 2010 at 7:20 pm By:
Aliskiren combination therapy helped improve systolic blood pressure http://ow.ly/1GUgv
Family Medicine Article | Hypertension
mdlinx.com — “The significance of low DBP in US adults with isolated systolic hypertension” View full resource at mdlinx.com
Most Recently Shared on May 5, 2011 at 12:27 pm By:
The significance of low DBP in US adults with isolated systolic hypertension: Journal of Hypertension http://bit.ly/lVxcDX #FamPractice
The significance of low DBP in US adults with isolated systo...
instapaper.com — “The significance of low DBP in US adults with isolated systo...” View full resource at instapaper.com
Most Recently Shared on May 20, 2011 at 5:11 am By:
Low diastolic blood pressure(<70) in elderly with isolated systolic #hypertension is associated with greater CVD risk: http://t.co/0HByMHi
Radiology Medical News about Hypertension
mdlinx.com — “Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: The LIFE study” View full resource at mdlinx.com
Most Recently Shared on May 30, 2010 at 11:46 am By:
Dr Dr ACK Larstorp just commented on: Changes in electrocardiographic left ventricular hypertrophy ... http://bit.ly/cHGw5k #author #mdlinx
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study : The Lancet
thelancet.com — “Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. By - Prof Henry Krum PhD, Markus Schlaich MD, Rob Whitbourn MBBS, ...” View full resource at thelancet.com
Most Recently Shared on September 29, 2009 at 12:54 pm By:
Renal Sympathectomy - a choice for resistant hypertension - http://bit.ly/163mvW
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study : The Lancet
thelancet.com — “Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. By - Prof Henry Krum PhD, Markus Schlaich MD, Rob Whitbourn MBBS, ...” View full resource at thelancet.com
Most Recently Shared on April 10, 2009 at 10:24 am By:
[The Lancet] [Articles] Catheter-based renal sympathetic denervation for resistant hypertension: a m.. http://tinyurl.com/cxtqd9
Medical News: Blood Pressure Target May Be Too High - in Cardiovascular, Hypertension from MedPage Today
medpagetoday.com — “Lowering systolic blood pressure below the current recommended target for patients with hypertension improves heart health without increasing side effects, a new industry-funded Italian study found.” View full resource at medpagetoday.com
Most Recently Shared on August 14, 2009 at 2:43 pm By:
Blood Pressure Target May Be Too High (CME/CE) http://ow.ly/15L1cT
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial : The Lancet
thelancet.com — “A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. By - Prof Michael A Webe...” View full resource at thelancet.com
Most Recently Shared on October 24, 2009 at 4:20 am By:
Darusentan for drug-resistant hypertension - http://bit.ly/2WTS6Y
rs198389 effects on natriuretic-peptide assays and prognosis
theheart.org — “A single-nucleotide polymorphism associated with chronically raised natriuretic-peptide levels is common enough to potentially influence interpretation of BNP and NT-proBNP assays under some circumstances, researchers say; there is increasing evidence that the gene variant may enhance survival in some patient groups.” View full resource at theheart.org
Most Recently Shared on September 25, 2009 at 3:20 pm By:
heartwire: BNP-boosting gene variant hints at possible screening, cardioprotective roles http://bit.ly/iXaBG
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial : The Lancet
thelancet.com — “Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised c...” View full resource at thelancet.com
Most Recently Shared on April 3, 2010 at 5:09 am By:
ACCOMPLISH trial - nephroprotection in great extent with amlodipine and benazepril - http://bit.ly/aD1pTw
ACCOMPLISH 24-hour ABPM
theheart.org — “Investigators say the results support their earlier conclusions that the difference in morbidity and mortality was driven by a more effective combination therapy with the ACE inhibitor benazepril plus the calcium-channel blocker amlodipine and not by differences in blood pressure.” View full resource at theheart.org
Most Recently Shared on May 11, 2009 at 2:49 pm By:
heartwire: ACCOMPLISH: Systolic blood pressure with 24-hour monitoring no different in treatment arms http://bit.ly/oNRVQ
Very low-dose phentermine, plus topiramate, drops weight, cuts BP
theheart.org — “The highest dose of an investigational weight-loss therapy, a combination of very low-dose phentermine and controlled-release topiramate, reduces body weight by around 10% after a year of treatment and has favorable effects on blood pressure, according to analyses presented at a late-breaking trial session.” View full resource at theheart.org
Most Recently Shared on May 4, 2010 at 3:03 pm By:
New weight-loss drug combo on the horizon: The highest dose of an investigational weight-loss therapy, a combinati... http://bit.ly/cCmZME
Family Medicine Article | Blood Pressure
mdlinx.com — “Effect of Antihypertensive Agents on Blood Pressure Variability : The Natrilix SR Versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patients (X-CELLENT) Study” View full resource at mdlinx.com
Most Recently Shared on July 18, 2011 at 5:56 pm By:
Effect of Antihypertensive Agents on Blood Pressure Variability : The Natrilix SR Versus Candesarta... http://bit.ly/r1yGrr #FamPractice
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
OhioHealth
OhioHealth is a family of not-for-profit, faith-based hospitals and healthcare organizations serving patients in central Ohio since 1891
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
Advertisement

